Consultant Urological Surgeon, Southmead Health Services Trust
Honorary Senior Lecturer, University of Bristol, Department of Surgery
Director, Bristol Urological Institute
Mr Gillatt specializes in the treatment of urological cancer and he leads a high quality multidisciplinary, multispeciality team within Southmead Hospital. He was instrumental in setting up the cancer team in Urology at Southmead Hospital. The team includes ward nurses to act as liaison, 2 Macmillan Uro-Oncology nurses and, when required, palliative care nurses and stomatherapists. The palliative care team provides ward and outpatient support. The medical team hold multidisciplinary team meetings where cases are reviewed and discussed on a local and a regional basis. Mr Gillatt’s experience with helping to build this team has convinced him that to provide high quality cancer care requires resources to cater for the variety of needs of individual patients throughout their “cancer journey”.
Mr Gillatt has received several research grants to enable his team to undertake projects including the role of the novel inhibitory vascular endothelial growth factor (VEGF) isoform (VEGF 165b) in the treatment of prostate cancer. He has also investigated pro- and anti-angiogenic VEGF Isoforms in prostate cancer, the early detection of prostate cancer and studied the relationship between genetic factors and metabolism of carcinogens. Qualitative and quantitative measures of quality of life in patients with prostate cancer and their partners is a further interest, as is the impact on quality of life of the different methods of urinary diversion or bladder reconstruction following radical cystectomy.
Mr Gillatt was one of the founder members of the Bristol Urological Institute and, as a Trustee and member of the Medical Executive Committee, has had a great interest in the progress of the Institute over the last 13 years. He was the Director of Education in the early days and contributed much to the training of both under-graduate students and post-graduate doctors. He has published widely and presented at all the major urological meetings world-wide.He acts as an external examiner for MD theses and is regularly invited to be an expert reviewer for world class urological journals. He is the Chairman of the British Association of Urological Surgeons (BAUS) Section of Oncology and an elected full member of the BAUS Council.
Click here for further information